Talk:EarlySense

Neutrality?
This article is written IMHO like a company homepage. The list of executives/board members for such a company has nothing to do on WP. --MarmotteiNoZ 00:51, 4 July 2014 (UTC)
 * Thank you for the note, I have taken out the full list of executive members, leaving in only the management. — Preceding unsigned comment added by Hila Peleg (talk • contribs) 09:52, 15 September 2014 (UTC)
 * Made some significant changes, not finished yet but I think the disputed neutrality message can be removed. Yinonk (talk) 12:15, 19 June 2015 (UTC)
 * Said the undisclosed paid editor Yinonk. Doc James  (talk · contribs · email) 17:51, 17 October 2017 (UTC)

Some proposed changes
Change First section to: EarlySense EarlySense is a medical device company that develops contact-free and continuous monitoring solutions to help clinicians prevent patient deteriorations and prevent falls and pressure ulcers in hospitals, alternate care facilities and homes.[1] Founded in 2004, its headquarters are in Ramat Gan, Israel and Waltham, Massachusetts. [2] The EarlySense medical system is cleared by the US Food and Drug Administration[3] and has a CE mark[4]. Initially focused on the hospital-clinical environment, in 2015, the company applied its technology to the home health setting via OEM partnerships[5] [6] and its own consumer monitoring device[7]. The CEO of the company is Avner Halperin[8], and Tim O’Malley is the president of EarlySense Inc[1]. [1]http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=80546 [2]https://healthbusinessblog.com/2012/04/04/earlysense-contact-free-medical-monitor-discussion-with-ceo-avner-halperin/ [3]http://www.marketwatch.com/story/israel-stocks-up-fda-moves-on-2-medical-firms-2010-06-21?pagenumber=2 [4]http://www.globes.co.il/en/article-1000456538 [5]http://www.sensorsmag.com/components/earlysense-contact-free-and-continuous-patient-monitoring-technology-now-widely [6]http://www.mobihealthnews.com/46487/earlysense-samsung-unveil-direct-to-consumer-contact-free-sleep-monitor [7]https://wearablezone.com/news/live-by-earlysense/ [8]http://www.modernhealthcare.com/article/20120912/NEWS/309129953 Hila.Peleg (talk) 09:27, 23 October 2017 (UTC)


 * Thanks for posting, and for making a good faith effort to follow the policies and guidelines!
 * For doing citations in the future, there is a gadget in the toolbar that appears just above the edit window. In the top row, over to the right, it says "cite". If you click the triangle next to that, a new toolbar opens just below, and to the left in that one, is a window that says "templates".  There are templates for news, journals, website, etc.  Each of those has fields with little magnifying glasses.  If you fill in one of those fields (say the URL) and then click the magnifying glass, most of it will autofill. You can hand-fill what is missing.  Then just click "insert" at the bottom, and it will add the reference where ever the cursor is.
 * About the content ... some of this is redundant with things in the second paragraph, and in my view the "contact free" thing is not plain English; i understand that this is part of EarlySense' messaging (you all are doing a nice job of thumping that phrase) but the system is explained simply and clearly in the 2nd paragraph.
 * I guess we are missing the OEM thing and the CE mark thing. Can add that... Jytdog (talk) 20:18, 23 October 2017 (UTC)

Additional proposed changes
Corporate History EarlySense was founded in 2004 by former Emmunet CEO Avner Halperin. The company is privately held and has raised more than $100 million to date.

The company’s contact-free sensing technology in the clinical market helps healthcare providers detect patient deterioration early and improve clinical outcomes, including preventing pressure ulcers and falls as well as reducing length of stay.

In 2015, the company broadened its focus to include consumer home health monitoring devices, based on its clinical technology, marketed to the aging population, children and women’s health. This is an addition to its ongoing work in the medical market.

Market Patient monitoring is part of a rapidly-growing class of digital health devices. According to Frost & Sullivan research, based on a peer-reviewed study from Harvard School of Medicine, continuous patient monitoring has the potential to save the US healthcare system $15 billion annually, through reduced ICU length of stay as well as fewer surgeries and code blue events in the 750,000 currently unmonitored hospital beds.

The global remote patient monitoring market grew by 44% in 2016 to 7.1 million devices and is expected to grow to more than 50 million by 2021. Revenue for the market exceeded 7.5 billion Euro in 2016 and is expected to reach 32.4 billion Euro by 2021.

Milestones ·      In June 2009, EarlySense EverOn received FDA Clearance and CE Mark Certification

·      In April 2011, EarlySense opened US center of operations in Waltham, MA

·      In January 2013, EarlySense and Welch Allyn announced a strategic collaboration agreement

·      In March 2013, EarlySense was granted a United States Patent for Respiratory Trend Analysis Capability for its Contact-Free, Patient Safety Monitoring system

·      In January 2014, EarlySense Received FDA clearance for new bedside monitor

·      In September 2014, National Health Services Hospitals chose EarlySense to improve patient safety

·      In January 2015, EarlySense raised $20 Million in funding round led by Samsung ventures

·      In April 2015, EarlySense and Mitsui Japan Signed a strategic partnership agreement

·      In June 2016, EarlySense raised $25 million in funding in round led by Bank Hapoalim

·      In September 2016, EarlySense launched the InSight monitoring system for skilled nursing facilities

·      In January 2017, EarlySense launched consumer product Live for the aging population

·      In October 2017, EarlySense launched consumer product Percept for fertility tracking

Products

EarlySense’s products include a number of contact-free continuous monitoring solutions for medical institutions and consumer environments. The products are based on a proprietary contact-less piezo-electric sensor and advanced analytics.

Clinical Products

EarlySense All-in-One System, full scale integrated patient monitoring supervision platform for clinical environment.

InSight - patient monitoring supervision platform for non-acute facilities.

Consumer Digital Health Products

Live - health and sleep tracker for homecare and wellness.

Percept – home fertility and period tracker

Popular culture EarlySense central nurses’ station monitor as seen at All Saints Hospital on season 5 of "Nurse Jackie"

The EarlySense system can be seen in the American TV series "Nurse Jackie" and in the American TV series "Royal Pains".

Hila.Peleg (talk) 06:39, 26 October 2017 (UTC)
 * Nope, this is all great content for your website. This is not encyclopedic. The goal of Wikipedia is to provide content expressing enduring accepted knowledge from which people can learn; it is not marketing, not to consumers nor to investors.   This proposal is almost all sourced from press releases or churnalism based on press releases.  Do not try to turn this page into a proxy for EarlySense's webiste.  I understand that for somebody coming from public relations this can be a difficult pivot to make, but you must do, if you are going to work here in Wikipedia.  Please do read WP:PROMO. Jytdog (talk) 17:37, 26 October 2017 (UTC)

Some proposed changes
 Spintendo  ᔦᔭ   12:58, 4 December 2017 (UTC)

Corporate History
EarlySense was founded in 2004 by former Emmunet CEO Avner Halperin. The company is privately held and has raised more than $100 million to date.

The company produces contact-free sensing technology developed for clinical settings. In 2015, the company broadened its focus to include consumer home health monitoring devices, based on its clinical technology, marketed to the aging population, children and women’s health. This is an addition to its ongoing work in the medical market. Hila.Peleg (talk) 14:45, 31 October 2017 (UTC)